Elixir is actively exploring green hydrogen production opportunities, leveraging its gas assets and renewable energy potential in Mongolia. The company emphasizes a prudent approach to capital ...

The Launch-HTN trial is the largest trial of an aldosterone synthase inhibitor completed in participants with uncontrolled or treatment resistant hypertension – – Lorundrostat 50 mg once daily ...